Roche late Friday released results from two Phase III studies - dubbed MEERKAT and SANDCAT - evaluating the efficacy and ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from two Phase III studies ...

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Open Enrollment Help. Medicare can be complicated. But it doesn ...

Radio astronomy opens a window onto the invisible universe. While our eyes can detect visible light, countless objects in ...